Sep 15, 2023

11 Jul 2023 • 2 min read Carlsbad, CA (July 11, 2023) - RCE.ai, an innovative health tech company, has been chosen as one of the new participants in the prestigious Cedars-Sinai Accelerator program. This selection recognizes RCE.ai's groundbreaking advancements in healthcare technology and its potential to transform patient care. The Cedars-Sinai Accelerator, located in Los Angeles, California, is renowned for supporting early-stage companies developing cutting-edge solutions in healthcare. RCE.ai has gained recognition for its novel optical based technology and artificial intelligence (AI) platform, which is intended to empower healthcare providers in delivering patient care through real-time assessment and clinical decision support. By leveraging machine learning algorithms and deep data analysis, RCE.ai enables clinicians to make more informed decisions, optimize workflows, and potentially improve patient outcomes. "We are thrilled to be selected for the Cedars-Sinai Accelerator program," said Atandra Burman, Founder and CEO of RCE.ai. "This opportunity will allow us to collaborate with industry leaders, access valuable resources, and refine our solution to better address the evolving needs of patients and healthcare providers." The inclusion of RCE.ai in the accelerator program highlights the company's potential to revolutionize healthcare delivery and patient management. By integrating RCE's technology into clinical workflows, hospitals and healthcare systems can enhance efficiency, reduce costs, and ultimately improve patient satisfaction. Through the Cedars-Sinai Accelerator program, RCE.ai will have access to a range of resources, including mentorship from leading industry experts, guidance in business development and strategy, as well as connections to Cedars-Sinai's vast network of healthcare professionals. About Cedars-Sinai Accelerator: The Cedars-Sinai Accelerator program transforms healthcare quality, efficiency, and care delivery by helping entrepreneurs bring their innovative technology products to market. This three-month program, based in Los Angeles, California, provides companies with $100,000 in funding, mentorship from more than three hundred leading clinicians and executives, access to Cedars-Sinai, and exposure to a broad network of entrepreneurs and investors. Since 2016, the accelerator has helped dozens of companies transform healthcare delivery and patient care. About RCE.ai: RCE.ai, an AI based med tech company works towards the early detection of heart attacks. We have re-imagined the way cardiac proteins are monitored in the blood using a non-invasive transdermal technique. The instant reporting of one such protein, cardiac Troponin empowers emergency medicine physicians and cardiologists in the early assessment and appropriate risk stratification of patients presenting with chest pain. We currently are conducting clinical studies and undertaking premarket efforts. – 2 min read